Amidst the COVID-19 pandemic and subsequent vaccine rollout, pharmaceutical giants including Pfizer and Moderna have substantially increased their lobbying efforts, a National Pulse investigation has revealed.
The lobbying apparatuses at both vaccine-reliant companies - in terms of the number of lobbyists hired and the overall budget deployed to influence government officials - have seen dramatic increases since 2019.
The news comes one day after hidden camera footage revealed a Pfizer scientist admitting: "Basically, our organization is run on COVID money now."
Among Pfizer's robust lobbying team are alumni of Republican presidential administrations and Congressional offices.
David Schiappa, a longtime Republican staff member of the Senate holding the role of Secretary for Leader Mitch McConnell, is also lobbying for Pfizer.
Pfizer, which recently received approval for a third booster dose of its COVID-19 vaccine, has substantially increased its lobbying budget.
While Moderna retained just one lobbyist throughout all of 2019 and added one lobbyist the following year, in 2021, the company has already hired an additional twelve lobbyists, representing a 600 percent increase in the company's total lobbying force.
https://thenationalpulse.com/exclusive/pfizer-and-moderna-increase-lobbying-efforts/
No comments:
Post a Comment